Iatrogenic immunodeficiency-associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravis

被引:2
作者
Zha, Kate [1 ]
Silvestri, Nicholas J. [2 ]
机构
[1] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA
[2] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY 14260 USA
关键词
LYMPHOMA;
D O I
10.1002/mus.27485
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:E14 / E16
页数:3
相关论文
共 7 条
  • [1] Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature
    Balci, M. A.
    Pamuk, G. E.
    Unlu, E.
    Usta, U.
    Pamuk, O. N.
    [J]. LUPUS, 2017, 26 (11) : 1224 - 1227
  • [2] Mycophenolate mofetil for myasthenia gravis - An analysis of efficacy, safety, and tolerability
    Meriggioli, MN
    Ciafaloni, E
    Al-Hayk, KA
    Rowin, J
    Tucker-Lipscomb, B
    Massey, JM
    Sanders, DB
    [J]. NEUROLOGY, 2003, 61 (10) : 1438 - 1440
  • [3] EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil
    O'Neill, Brian Patrick
    Vernino, Steven
    Dogan, Ahmet
    Giannini, Caterina
    [J]. NEURO-ONCOLOGY, 2007, 9 (03) : 364 - 369
  • [4] Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature
    Rezania, Kourosh
    Soliven, Betty
    Baron, Joseph
    Lin, Helen
    Penumalli, Vikram
    van Besien, Koen
    [J]. LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 371 - 380
  • [5] Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil
    Robson, R
    Cecka, JM
    Opelz, G
    Budde, M
    Sacks, S
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (12) : 2954 - 2960
  • [6] Swerdlow SH, 2017, WHO CLASSIFICATION T, V4th
  • [7] Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
    Vernino, S
    Salomao, DR
    Habermann, TM
    O'Neill, BP
    [J]. NEUROLOGY, 2005, 65 (04) : 639 - 641